1. Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2000: Cancer Incidence, Mortality and Prevalence worldwide. Lyon: International Agency for Research on Cancer, 2001.
  2. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80:827-841.
  3. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. (eds) Cancer Incidence in Five Continents. Vol. VIII. Lyon: International Agency for Research on Cancer, 2002.
  4. Haenszel W, Correa P. Cancer of the colon and rectum and adenomatous polyps: a review of epidemiologic findings. Cancer 1971; 28:14-24.
  5. Sharp L. Current trends in colorectal cancer: what they tell us and what we still do not know. Clin Oncol 2001; 13:444-447.
  6. Thorn M, Bergstrom R, Kressner U, Sparen P, Zack M, Ekbom A. Trends in colorectal cancer incidence in Sweden 1959-93 by gender, localization, time period, and birth cohort. Cancer Causes Control 1998; 9:145-152.
  7. Johansen C, Mellemgaard A, Skov T, Kjaergaard J, Lynge E. Colorectal cancer in Denmark 1943-1988. Int J Colorectal Dis 1993; 8:42-47.
  8. Lopez-Abente G, Pollan M, Vergara A, et al. Age-period-cohort modeling of colorectal cancer incidence and mortality in Spain. Cancer Epidemiol Biomarkers Prev 2001; 6:999-1005.
  9. De Angelis R, Valente F, Frova L, et al. Trends of colorectal cancer incidence and prevalence in Italian regions. Tumori 1998; 84:1-8.
  10. Bell JC. Trends in colorectal cancer incidence and mortality in New South Wales 1973-1992. Med J Aust 1996; 166:175-176.
  11. Cox B, Little J. Reduced risk of colorectal cancer among recent generations in New Zealand. Br J Cancer 1992; 66:386-390.
  12. Hayne D, Brown RSD, McCormack M, Quinn MJ, Payne HA, Babb P. Current trends in colorectal cancer: site, incidence, mortality and survival in England and Wales. Clin Oncol 2001; 13:448-452.
  13. Black RJ, Macfarlane GJ, Maisonneuve P, Boyle P. Cancer Incidence and Mortality in Scotland, 1960-1989. Edinburgh: Common Services Agency, 1995.
  14. Harris V, Sandridge AL, Black RJ, Brewster DH, Gould A. Cancer Registration Statistics Scotland, 1986-1995. Edinburgh: ISD Scotland Publications, 1998.
  15. Reis LAG, Wingo PA, Miller DS, et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 2000; 88:2398-2424.
  16. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. (eds) Cancer Incidence in Five Continents. Volume VII. Lyon: International Agency for Research on Cancer, 1997.
  17. Jass JR. Subsite distribution and incidence of colorectal cancer in New Zealand 1974-1983. Dis Colon Rectum 1991; 34:56-59.
  18. Devesa SS, Chow WH. Variation in colorectal cancer incidence in the United States by subsite of origin. Cancer 1993; 71:3819-3826.
  19. dos Santos Silva I, Swerdlow AJ. Sex differences in time trends of colorectal cancer in England and Wales: the possible effect of female hormonal factors. Br J Cancer 1996; 73:692-697.
  20. Rabeneck L, Davila JA, El-Serag HB. Is there a true "shift" to the right colon in the incidence of colorectal cancer?. Am J Gastroenterol 2003; 98:1400-1409.
  21. Grulich AE, Swerdlow AJ, Head J, Marmot MG. Cancer mortality in African and Caribbean migrants to England and Wales. Br J Cancer 1992; 66:905-911.
  22. Faggiano F, Partanen T, Kogevinas M, Boffetta P. Socioeconomic differences in cancer incidence and mortality. In: Kogevinas M, Pearce N, Susser M, Boffetta P, eds. Social Inequalities and Cancer. IARC Scientific Publications No. 138. Lyon: International Agency for Research on Cancer, 1997:65-176.
  23. Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H. Trends in Cancer Incidence and Mortality. Lyon: International Agency for Research on Cancer, 1993.
  24. Robinson MHE, Thomas WM, Hardcastle JD, Chamberlain J, Mangham CM. Change towards earlier stage at presentation of colorectal cancer. Br J Surg 2002; 80:1610-1612.
  25. Chu KC, Tarone RE, Chow WH, Hankey BF, Ries LAG. Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990. J Natl Cancer Inst 2002; 86:997-1006.
  26. Sant M, Capocaccia R, Coleman MP, et al., EUROCARE Working Group. Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer 2001; 37:1659-1667.
  27. Gatta G, Ciccolallo L, Capocaccia R, et al. Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology. Eur J Cancer 2003; 39:2214-2222.
  28. Gillen C, Walmsley RS, Prior P, Andrews HA, Allan RN. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 1994; 35:1590-1592.
  29. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48:526-535.
  30. Cotton S, Sharp L, Little J. The adenoma-carcinoma sequence and prospects for the prevention of colorectal neoplasia. Crit Rev Oncogen 1996; 7(5&6):293-342.
  31. Winawer SJ, O'Brien MJ, Waye JD, et al. Risk and surveillance of individuals with colorectal polyps. Bull World Health Organ 1990; 68:789-795.
  32. Peipins LA, Sandler RS. Epidemiology of colorectal adenomas. Epidemiol Rev 1994; 16:273-297.
  33. Hawkins NJ, Ward RL. Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polpys and serrated adenomas. J Natl Cancer Inst 2001; 93:1307-1313.
  34. Mecklin JP, Ponz de Leon M. Epidemiology of HNPCC. Anticancer Res 1994; 14:1625-1629.
  35. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC. A prospective study of family history and the risk of colorectal cancer. N Engl J Med 1994; 331:1669-1674.
  36. Winawer SJ, Zauber AG, Gerdes H, et al. Risk of colorectal cancer in the families of patients with adenomatous polyps. N Engl J Med 1996; 334:82-87.
  37. Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 2001; 96:2992-3003.
  38. Khoury MJ, Beaty TH, Liang KY. Can familial aggregation of disease be explained by familial aggregation of environmental risk factors? Am J Epidemiol 1988; 127:674-683.
  39. Haenszel W, Kurihara M. Studies of Japanese migrants: mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 1968; 40:43-68.
  40. Friedenreich CM. Physical activity and cancer prevention: from observational to intervention research. Cancer Epidemiol Biomarkers Prev 2001; 10: 287-301.
  41. McTiernan A, Ulrich C, Slate S, Potter J. Physical activity and cancer etiology: associations and mechanisms. Cancer Causes Control 1998; 9:487-509.
  42. IARC Working Group. IARC Handbooks of Cancer Prevention Vol. 6. In: The Role of Weight Control and Physical Activity in Cancer Prevention. Lyon: International Agency for Research on Cancer, 2002.
  43. Terry MB, Neugut AI, Bostick RM, et al. Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev 2002; 11:622-629.
  44. Bergstrom A, Pisani P, Tenet V, Wolk A, Adami HO. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001; 91:421-430.
  45. Bird CL, Frankl HD, Lee ER, Haile RW. Obesity, weight gain, large weight changes, and adenomatous polyps of the left colon and rectum. Am J Epidemiol 1998; 147:670-680.
  46. Boutron-Ruault MC, Senesse P, Belghiti C, Faivre J. Energy intake, body mass index, physical activity, and the colorectal adenoma-carcinoma sequence. Nutr Cancer 2001; 39:50-57.
  47. Martinez ME, McPherson RS, Levin B, Glober GA. A case-control study of dietary intake and other lifestyle risk factors for hyperplastic polyps. Gastroenetrology 1997; 113:423-429.
  48. Morimoto LM, Newcomb PA, Ulrich CM, Bostick RM, Lais CJ, Potter JD. Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential? Cancer Epidemiol Biomarkers Prev 2002; 11:1012-1018.
  49. Lieberman DA, Prindiville S, Weiss DG, Willet W. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA 2003; 290:2959-2967.
  50. Giovannucci E. An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2001; 10:725-731.
  51. IARC Working Group. IARC Monograph on the Evaluation of Carcinogenic Risks to Humans. Volume 83: Tobacco Smoke and Involuntary Smoking. Lyon: International Agency for Research on Cancer, 2004.
  52. de Jong MM, Nolte IM, te Meerman GJ, et al. Low-penetrance genes and their involvement in colorectal cancer susceptibility. Cancer Epidemiol Biomarkers Prev 2002; 11:1332-1352.
  53. Smits KM, Gaspari L, Weijenberg MP, et al. Interaction between smoking, GSTM1 deletion and colorectal cancer: results from the GSEC study. Biomar kers 2003; 8:299-310.
  54. Ye Z, Parry JM. A meta-analysis of 20 case-control studies of the glutathione transferase M1 (GSTM1) status and colorectal cancer risk. Med Sci Monit 2003; 9:SR83-SR91.
  55. Cotton SC, Sharp L, Little J, Brockton N. Glutathione S-transferase polymorphisms and colorectal cancer. Am J Epidemiol 2000; 151:7-32.
  56. Ioannidis JPA, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001; 29:306-309.
  57. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehesive review of genetic association studies. Genet Med 2002; 4:45-61.
  58. Katoh T, Nagata N, Kuroda Y, et al. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis 1996; 17:1855-1859.
  59. Gertig DM, Stampfer M, Haiman CH, Hennekens CH, Kelsey K, Hunter DJ. Glutathione S-Transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: a prospective study. Cancer Epidemiol Biomarkers Prev 1998; 7:1001-1005.
  60. Slattery ML, Potter JD, Samowitz W, Bigler J, Caan B, Leppert M. NAT2, GSTM-1, cigarette smoking, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 1998; 7:1079-1084.
  61. Slattery ML, Edwards S, Curtin K, Schaffer D, Neuhausen S. Associations between smoking, passive smoking, GSTM-1, NAT2, and rectal cancer. Cancer Epidemiol Biomarkers Prev 2003; 12:882-889.